Monopar Therapeutics
Monopar Therapeutics Logo
About Monopar Therapeutics
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel radiopharmaceuticals and therapeutics for the treatment of cancer and rare diseases, including Wilson Disease. Its pipeline includes radiodiagnostic and radiotherapeutic agents for advanced solid tumors, as well as ALXN1840, a late-stage investigational drug for Wilson Disease. Monopar advances its drug development pipeline through in-house research and licensing, aiming to improve clinical outcomes for patients with limited treatment options.
Address
1000 Skokie Boulevard, Suite 350
Wilmette, 60091
United States
Year founded
2014
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
